Results 141 to 150 of about 2,232 (156)

Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma

Frontiers in Immunology, 2019
Gyu Tae Park, Tae Wook Lee
exaly  

In Vitro Growth Enhancement of Ectomycorrhizal Fungus Scleroderma Bovista by Two Mycorrhizosphere Bacteria

, 2015
Anurag Yadav, Ramesh Chandra Dubey, Kusum Yadav   +2 more
openalex  

Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases

Experimental Dermatology, 2007
Takashi Matsushita, Minoru Hasegawa
exaly  

Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma

International Journal of Rheumatic Diseases, 2016
Chingching Foocharoen, Ajanee Mahakkanukrauh, Ratanavadee Nanagara   +2 more
exaly  

Scleroderma in South Australia: epidemiological observations of possible pathogenic significance

Internal Medicine Journal, 2001
P Barria
exaly  

Diagnosis and Therapy of Localized Scleroderma

JDDG - Journal of the German Society of Dermatology, 2009
Alexander Kreuter, Margitta Worm, Jörg Wenzel   +2 more
exaly  

The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: An evaluation of their measurement properties

Arthritis and Rheumatism, 2005
Sindhu R Johnson
exaly  

Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation

Internal Medicine Journal, 2006
Geza Benke
exaly  

Localized scleroderma

Dermatologic Therapy, 2012
Alexander Kreuter
exaly  

Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective

Experimental Dermatology, 2005
exaly